|
Anirban Basu, Ph.D. Assistant Professor Department of Medicine, Section of Hospital Medicine, University of Chicago |
|
Anirban Basu (MS Biostatistics, UNC- Chapel Hill, PhD Public Policy, University of Chicago) is an Assistant Professor of Medicine at the University of Chicago and is affiliated with the Chicago Center for Health and the Social Sciences and the University of Chicago Cancer Research Foundation. He is also a faculty research fellow at the National Bureau of Economic Research. Dr. Basu’s research interests lie in revealing heterogeneity in clinical and economic outcomes in order to establish the value of individualized care and translating such information for public policy using innovative methods in comparative effectiveness and cost-effectiveness research. Specifically, Dr. Basu strives to apply micro-econometric theory and models to health economic evaluations. Dr. Basu has extensive experience in modeling health expenditure data and has also worked on the theoretical and empirical foundations in cost-effectiveness analyses and value of information analyses in the context of prostate cancer and schizophrenia. Some of his work include establishing the value of individualized care based on patient preferences, developing models to predict quality of life of patients with multiple comorbidities, measuring the effect of patients’ health on the quality of life of their partners, estimating the future value of research in diagnosing and finding a cure for Duchenne muscular dystrophy, developing simulation models for evaluating the cost-effectiveness of pharmacological treatment algorithms in schizophrenia, and comparative effectiveness research on the dynamic intensification of glucose lowering therapies in diabetes. In 2005, Dr. Basu was awarded the NARSAD Wodecroft Young Investigator Award for his work on modeling the long-term risk of diabetes and cardiovascular disease due to atypical antipsychotics medications in patients with schizophrenia. He is also the recipient of the 2007 Research Excellence Award for Methodological Excellence from the International Society for Pharmacoeconomics and Outcomes Research, and the 2008 Alan Williams Health Economics Fellowship from the University of York, UK. |
|
Last Updated: March 10, 2009 |